发明申请
US20140161899A1 METHODS TO REDUCE ADVERSE EVENTS CAUSED BY PHARMACEUTICAL PREPARATIONS COMPRISING PLASMA DERIVED PROTEINS
审中-公开
减少包含等离子体衍生蛋白质的药物制剂引起的不良事件的方法
- 专利标题： METHODS TO REDUCE ADVERSE EVENTS CAUSED BY PHARMACEUTICAL PREPARATIONS COMPRISING PLASMA DERIVED PROTEINS
- 专利标题（中）： 减少包含等离子体衍生蛋白质的药物制剂引起的不良事件的方法
-
申请号： US14116491申请日： 2012-05-14
-
公开(公告)号： US20140161899A1公开(公告)日： 2014-06-12
- 发明人: Stefan Schulte , Uwe Kalina , Michael Moses , Annette Feussner
- 申请人： Stefan Schulte , Uwe Kalina , Michael Moses , Annette Feussner
- 优先权： EP11165869.6 20110512
- 国际申请： PCT/EP2012/058954 WO 20120514
- 主分类号： A61K35/16
- IPC分类号： A61K35/16
摘要：
The instant invention provides a method to reduce adverse events caused by a pharmaceutical preparation derived from a plasma fraction wherein the method comprises contacting the plasma fraction with heparin or a heparin-like substance thereby reducing the activity of at least one activated serine proteaseper ml of the plasma fraction.
公开/授权文献
信息查询
IPC分类:
